Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 04, 2015 7:49 PM ET

Biotechnology

Company Overview of FORMA Therapeutics, Inc.

Company Overview

FORMA Therapeutics, Inc. discovers and develops medicines in cancer and other genetically-driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company has a strategic partnership with Celgene Corporation. FORMA Therapeutics, Inc. was formerly known as Forma Pharmaceuticals, Inc. and changed its name to FORMA Therapeutics, Inc. in February 2008. The company was incorporated in 2007 and is based in Watertown, Massachusetts. It has additional chemistry operations in Branford, Connecticut.

500 Arsenal Street

Suite 100

Watertown, MA 02472

United States

Founded in 2007

Phone:

617-679-1970

Fax:

617-679-1977

Key Executives for FORMA Therapeutics, Inc.

Co-Founder, Chief Executive Officer, President and Director
Co-Founder and Director
Co-Founder and Vice President of Discovery Biology
Age: 52
Chief Financial Officer
Head of Biomolecular Screening and Executive Director
Compensation as of Fiscal Year 2014.

FORMA Therapeutics, Inc. Key Developments

FORMA Therapeutics, Inc. Appoints Paolo Paoletti as a Board of Directors

FORMA Therapeutics announced the appointment of Paolo Paoletti as a Board of Directors. In addition to serving as a director, Dr. Paoletti will also lead FORMA’s Research & Development Committee as its chairperson; in this capacity, his strategic clinical and research insights will be applied to FORMA’s target family drug discovery paradigm. Dr. Paoletti held several executive leadership roles in oncology at GSK, including Head of Oncology R&D Unit, Member of the Executive Board for Portfolio Investment and Chairman of the Oncology Portfolio Board. In his global leadership roles, he maintained the accountability for GSK’s entire oncology business and was responsible for drug discovery from target identification through registration, including product life cycle management and commercial strategy.

FORMA Therapeutics and Cancer Research Technology Form Two Virtual Companies to Advance Deubiquitination Assets

FORMA Therapeutics and Cancer Research Technology Ltd. announced the formation of two new virtual Asset Discovery and Development Companies (ADDCos) with novel chemical matter targeting undisclosed deubiquitinating enzymes (DUBs). ADDCos are virtual companies seeking to achieve rapid innovation in a compelling scientific area through the collaboration of academic thought leaders, FORMA drug discovery scientists and a world class development network. This builds on an ongoing initiative between FORMA and CRT, the commercial arm of Cancer Research UK, to discover innovative tools, technologies and therapeutic drug candidates against a variety of DUBs that regulate protein homeostasis. Under their agreement, FORMA is pairing its ultra-efficient drug discovery capabilities with expertise from CRT's Discovery Laboratories (CRT-DL) in translating academic discoveries and the exclusive world class academic network of Cancer Research UK scientists.

FORMA Therapeutics, Inc. Presents at Boston Biotech Conferences LLC's The East Meets West CEO conference, Jan-11-2015 09:30 AM

FORMA Therapeutics, Inc. Presents at Boston Biotech Conferences LLC's The East Meets West CEO conference, Jan-11-2015 09:30 AM. Venue: Four Seasons Hotel, 757 Market St, San Francisco, CA 94103, United States. Speakers: Steven Tregay, Co-Founder, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
New Horizons Diagnostic Corp. United States
Alinea Pharmaceuticals, Inc. United States
Bio-NEMS Corporation United States
Nittobo America Incorporated United States
Frederic-Ernest Agricultural Group, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FORMA Therapeutics, Inc., please visit www.formatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.